![]() |
Volumn 32, Issue 3, 2009, Pages
|
Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the american diabetes association and the european association for the study of diabetes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA GLUCOSIDASE INHIBITOR;
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
GLIBENCLAMIDE;
GLITAZONE DERIVATIVE;
GLUCOSE;
INSULIN;
METFORMIN;
ROSIGLITAZONE;
ALGORITHM;
COST BENEFIT ANALYSIS;
DIABETIC PATIENT;
DRUG COST;
GLUCOSE BLOOD LEVEL;
HEART INFARCTION;
HUMAN;
HYPERGLYCEMIA;
LETTER;
MEDICAL SOCIETY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRACTICE GUIDELINE;
SELF MONITORING;
ALGORITHMS;
DIABETES MELLITUS, TYPE 2;
EUROPE;
EVIDENCE-BASED MEDICINE;
HUMANS;
HYPERGLYCEMIA;
HYPOGLYCEMIC AGENTS;
METFORMIN;
SOCIETIES, MEDICAL;
THIAZOLIDINES;
UNITED STATES;
|
EID: 64749114317
PISSN: 01495992
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc08-2093 Document Type: Letter |
Times cited : (5)
|
References (6)
|